| Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung … YK Chae, A Arya, W Iams, MR Cruz, S Chandra, J Choi, F Giles Journal for immunotherapy of cancer 6, 1-27, 2018 | 411 | 2018 |
| Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer L Formisano, Y Lu, A Servetto, AB Hanker, VM Jansen, JA Bauer, ... Nature communications 10 (1), 1373, 2019 | 306 | 2019 |
| Epithelial-mesenchymal transition (EMT) signature is inversely associated with T-cell infiltration in non-small cell lung cancer (NSCLC) YK Chae, S Chang, T Ko, J Anker, S Agte, W Iams, WM Choi, K Lee, ... Scientific reports 8 (1), 2918, 2018 | 220 | 2018 |
| Targeting Epidermal Growth Factor Receptor in triple negative breast cancer: New discoveries and practical insights for drug development R Costa, AN Shah, CA Santa-Maria, MR Cruz, D Mahalingam, ... Cancer treatment reviews 53, 111-119, 2017 | 182 | 2017 |
| Clinical features, diagnostic challenges, and management strategies in checkpoint inhibitor-related pneumonitis S Chuzi, F Tavora, M Cruz, R Costa, YK Chae, BA Carneiro, FJ Giles Cancer management and research, 207-213, 2017 | 156 | 2017 |
| Meningeal carcinomatosis in breast cancer: prognostic factors and outcome CRAS De Azevedo, MRS Cruz, LTD Chinen, SV Peres, MA Peterlevitz, ... Journal of neuro-oncology 104, 565-572, 2011 | 141 | 2011 |
| Lung cancer in Brazil LH Araujo, C Baldotto, G Castro Jr, A Katz, CG Ferreira, C Mathias, ... Jornal Brasileiro de Pneumologia 44, 55-64, 2018 | 133 | 2018 |
| Clinical implications of circulating tumor DNA tumor mutational burden (ctDNA TMB) in non‐small cell lung cancer YK Chae, AA Davis, S Agte, A Pan, NI Simon, WT Iams, MR Cruz, ... The oncologist 24 (6), 820-828, 2019 | 107 | 2019 |
| Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE) T Bachelot, E Ciruelos, A Schneeweiss, F Puglisi, T Peretz-Yablonski, ... Annals of Oncology 30 (5), 766-773, 2019 | 107 | 2019 |
| Chemotherapy for advanced non‐small cell lung cancer in the elderly population FN Santos, TB de Castria, MRS Cruz, R Riera Cochrane Database of Systematic Reviews, 2015 | 80 | 2015 |
| Câncer de pulmão no Brasil LH Araujo, C Baldotto, G Castro Jr, A Katz, CG Ferreira, C Mathias, ... Jornal Brasileiro de Pneumologia 44, 55-64, 2018 | 67 | 2018 |
| Meningeal carcinomatosis in solid tumors SJ Martins, CRAS Azevedo, LTD Chinen, MRS Cruz, MA Peterlevitz, ... Arquivos de neuro-psiquiatria 69, 973-980, 2011 | 48 | 2011 |
| Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a … D Miles, E Ciruelos, A Schneeweiss, F Puglisi, T Peretz-Yablonski, ... Annals of Oncology 32 (10), 1245-1255, 2021 | 46 | 2021 |
| Fertility preservation in women with breast cancer undergoing adjuvant chemotherapy: a systematic review MRS Cruz, JC Prestes, DL Gimenes, MF Fanelli Fertility and sterility 94 (1), 138-143, 2010 | 45 | 2010 |
| Emergence of FGFR3-TACC3 fusions as a potential by-pass resistance mechanism to EGFR tyrosine kinase inhibitors in EGFR mutated NSCLC patients SHI Ou, L Horn, M Cruz, D Vafai, CM Lovly, A Spradlin, MJ Williamson, ... Lung Cancer 111, 61-64, 2017 | 44 | 2017 |
| Overexpression of adhesion molecules and barrier molecules is associated with differential infiltration of immune cells in non-small cell lung cancer YK Chae, WM Choi, WH Bae, J Anker, AA Davis, S Agte, WT Iams, M Cruz, ... Scientific reports 8 (1), 1023, 2018 | 41 | 2018 |
| VEGF-A levels in bevacizumab-treated breast cancer patients: a systematic review and meta-analysis LV Dos Santos, MR Cruz, G Lima Lopes, JPSN Lima Breast cancer research and treatment 151, 481-489, 2015 | 39 | 2015 |
| Combination of afatinib with cetuximab in patients with EGFR-mutant non-small-cell lung cancer resistant to EGFR inhibitors J Ribeiro Gomes, MRS Cruz OncoTargets and therapy, 1137-1142, 2015 | 32 | 2015 |
| Timing of adjuvant chemotherapy in colorectal cancer LV Dos Santos, TMV Faria, ABC Lima, KC Abdalla, ED de Moraes, ... Colorectal Disease 18 (9), 871-876, 2016 | 30 | 2016 |
| Clinical response to sorafenib in a patient with metastatic colorectal cancer and FLT3 amplification R Brandão Moreira, R D''Alpino Peixoto, M Rocha de Sousa Cruz Case Reports in Oncology 8 (1), 83-87, 2015 | 26 | 2015 |
